Syed Yousuf Zafar, MD

Associate Professor of Medicine
Associate Professor in the Sanford School of Public Policy
Affiliate, Duke Global Health Institute
Member of the Duke Cancer Institute
Member in the Duke Clinical Research Institute
Campus mail Duke Box 3505, Durham, NC 27710
Phone (919) 684-8111
Email address yousuf.zafar@duke.edu

Dr. Zafar is a health services researcher with a focus in improving care delivery for patients with advanced cancer. He has obtained advanced training in health services research and has participated in single-institution, multi-institution and national studies focusing on access to care, cost of care, and comparative effectiveness of care delivery between health systems. His primary area of interest is in the cost of cancer care. He has conducted institutional and national studies on how treatment-related costs impact cancer patients' experience. His current work in this arena is focused on patient preferences regarding cost-related communication and decision-making.

A second field of interest is palliative care. Dr. Zafar has collaborated with national and international palliative care leaders to improve the design and delivery of palliative care in cancer clinical trials. Methodologically, this work has centered around systematic literature reviews, iterative surveys, and prospective clinical trials.

Dr. Zafar is a member of the American Society of Clinical Oncology’s Health Disparities and Clinical Practice Guideline Committees. He is a member of the Alliance for Clinical Trials in Oncology's Health Disparities and Health Outcomes Committees. Dr. Zafar's work has been funded by the American Cancer Society, the HealthWell Foundation, the Duke Cancer Prevention and Control Program, the Duke Clinical Research Institute, and the CALGB Foundation.

In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Duke University, 2005 - 2008
  • Resident, Medicine, University of Cincinnati, 2002 - 2005
  • M.D., University of Toledo, 2002

Publications

Hastert, TA, Young, GS, Pennell, ML, Padamsee, T, Zafar, SY, DeGraffinreid, C, Naughton, M, Simon, M, and Paskett, ED. "Financial burden among older, long-term cancer survivors: Results from the LILAC study." Cancer Medicine (July 17, 2018).

PMID
30019387
Full Text

Vlahovic, G, Meadows, KL, Hatch, AJ, Jia, J, Nixon, AB, Uronis, HE, Morse, MA, Selim, MA, Crawford, J, Riedel, RF, Zafar, SY, Howard, LA, O'Neill, M, Meadows, JJ, Haley, ST, Arrowood, CC, Rushing, C, Pang, H, and Hurwitz, HI. "A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer." The Oncologist 23, no. 7 (July 2018): 782-790.

PMID
29572245
Full Text

Leopold, C, Peppercorn, JM, Zafar, SY, and Wagner, AK. "Defining Value of Cancer Therapeutics-A Health System Perspective." Journal of the National Cancer Institute 110, no. 7 (July 2018): 699-703.

PMID
29788313
Full Text

Chino, F, Suneja, G, Moss, H, Zafar, SY, Havrilesky, L, and Chino, J. "Health Care Disparities in Cancer Patients Receiving Radiation: Changes in Insurance Status After Medicaid Expansion Under the Affordable Care Act." May 2018.

PMID
29398128
Full Text

Chan, RJ, Gordon, L, Zafar, SY, and Miaskowski, C. "Financial toxicity and symptom burden: what is the big deal? (Accepted)." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 26, no. 5 (May 2018): 1357-1359.

PMID
29435714
Full Text

Tran, G, and Zafar, SY. "Financial toxicity and implications for cancer care in the era of molecular and immune therapies." Annals of Translational Medicine 6, no. 9 (May 2018): 166-null. (Review)

PMID
29911114
Full Text

Shih, Y-CT, Nasso, SF, and Zafar, SY. "Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care." PharmacoEconomics 36, no. 3 (March 2018): 259-261.

PMID
29396743
Full Text

Tran, G, and Zafar, SY. "Price of Cancer Care and Its Tax on Quality of Life." Journal of Oncology Practice 14, no. 2 (February 2018): 69-71.

PMID
29381412
Full Text

Moss, HA, Havrilesky, LJ, Zafar, SY, Suneja, G, and Chino, J. "Trends in Insurance Status Among Patients Diagnosed With Cancer Before and After Implementation of the Affordable Care Act." Journal of Oncology Practice 14, no. 2 (February 2018): e92-e102.

PMID
29436303
Full Text

Williams, GR. "Geriatric Assessment: Precision Medicine for Older Adults With Cancer." Journal of Oncology Practice 14, no. 2 (February 2018): 97-98.

Full Text

Pages